Triple Negative Breast Cancer Diagnostics Market Research Insights 2022-28

Triple Negative Breast Cancer Diagnostics Market size was valued at USD 11,401.2 million in 2021. It is expected to reach USD 21.422.3 million by 2028, registering a CAGR of 10.09% over the forecast period 2022-2028. Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps that may be nonmalignant or malignant in nature. Breast cancer is a heterogeneous disease disease that can be sub divided into clinical, histo pathological and molecular subtypes

Source: https://precisionbusinessinsights.com/market-reports/triple-negative-breast-cancer-diagnostics-market/